BOLZATI, CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 3.709
NA - Nord America 1.915
EU - Europa 842
SA - Sud America 674
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 5
Totale 7.244
Nazione #
US - Stati Uniti d'America 1.763
SG - Singapore 1.514
CN - Cina 907
BR - Brasile 536
HK - Hong Kong 368
VN - Vietnam 355
FR - Francia 221
IT - Italia 221
KR - Corea 179
NL - Olanda 111
BD - Bangladesh 103
CA - Canada 79
GB - Regno Unito 74
JP - Giappone 71
IN - India 58
AR - Argentina 51
DE - Germania 46
ID - Indonesia 28
FI - Finlandia 25
MX - Messico 23
IL - Israele 22
PL - Polonia 21
CO - Colombia 20
EC - Ecuador 17
JM - Giamaica 17
ZA - Sudafrica 17
IQ - Iraq 16
RU - Federazione Russa 15
ES - Italia 13
PH - Filippine 13
VE - Venezuela 12
PK - Pakistan 11
PY - Paraguay 11
BE - Belgio 10
UA - Ucraina 10
EG - Egitto 9
PE - Perù 9
CL - Cile 8
CR - Costa Rica 8
IE - Irlanda 8
TR - Turchia 8
UY - Uruguay 8
UZ - Uzbekistan 8
BG - Bulgaria 7
GR - Grecia 7
MY - Malesia 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
LT - Lituania 6
SA - Arabia Saudita 6
AT - Austria 5
AZ - Azerbaigian 5
KG - Kirghizistan 5
NI - Nicaragua 5
RO - Romania 5
SE - Svezia 5
ET - Etiopia 4
HN - Honduras 4
MA - Marocco 4
PT - Portogallo 4
SN - Senegal 4
AU - Australia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
TH - Thailandia 3
BZ - Belize 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
Totale 7.196
Città #
Singapore 888
Santa Clara 486
Hong Kong 363
Hefei 356
San Jose 282
Seoul 178
Lauterbourg 170
Beijing 144
Ashburn 139
Ho Chi Minh City 112
Hanoi 80
Los Angeles 74
Dallas 67
Tokyo 48
São Paulo 46
Guangzhou 45
New York 35
Buffalo 28
Toronto 23
Frankfurt am Main 21
Milan 21
Minamishinagawa 20
Rio de Janeiro 19
Warsaw 18
Rome 17
Brasília 16
Haiphong 16
Bengaluru 15
Montreal 15
Phoenix 14
Biên Hòa 13
Da Nang 13
London 13
Helsinki 12
Hải Dương 12
Chicago 11
Belo Horizonte 10
Brooklyn 10
Bari 9
Elk Grove Village 9
Naples 9
Atlanta 8
Brussels 8
City of London 8
Council Bluffs 8
Dublin 8
Goiânia 8
Johannesburg 8
Newark 8
Orem 8
Philadelphia 8
Recife 8
Shanghai 8
Athens 7
Campinas 7
Can Tho 7
Chennai 7
Guarulhos 7
Guayaquil 7
Lima 7
Manchester 7
Munich 7
Ottawa 7
Padova 7
Tashkent 7
Verona 7
Amsterdam 6
Asunción 6
Belém 6
Boardman 6
Curitiba 6
Fortaleza 6
Houston 6
Lappeenranta 6
Manaus 6
Salvador 6
San José 6
Alexandria 5
Baghdad 5
Baku 5
Boston 5
Bình Dương 5
Dhaka 5
Düsseldorf 5
Ha Long 5
Kingston 5
Montevideo 5
Poplar 5
Quận Bình Thạnh 5
Quận Một 5
Turku 5
Vienna 5
Bishkek 4
Bologna 4
Cairo 4
Catania 4
Contagem 4
Dakar 4
Glasgow 4
Itajaí 4
Totale 4.237
Nome #
Copper(II) and copper(I) complexes with a bidentate hydrazinic dithiocarbazate: synthesis and crystal structures 96
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 93
Pharmacological characterization of alpha-MSH-derivatives 92
Preclinical dosimetric studies of Lu-177-scFvD2B and comparison with Lu-177-PSMA-617 and Lu-177-iPSMA endoradiotherapeutic agents 89
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 79
N, n-(dialkylamino)-alkyl substituted Tc-99m-amineamidedithiol (AADT) complexes as diagnostic probes for melanoma. 79
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 75
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 73
A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer 73
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 69
Evaluation of [99mTc]Tc(CO)3+ moiety labeled ?-melanocyte stimulating hormone derived peptide conjugatesfor potential melanoma imaging 68
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and Tc-99m-radiolabelling 68
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 67
IMPACT OF DIFFERENT [Tc(N)PNP]-FRAMEWORKS ON THE PHARMACOKINETICS OF THE SMALL RGDFK PEPTIDE 67
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 63
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 63
Compendio di radiochimica e radiofarmacia : Radiofarmaci marcati con tecnezio-99m 63
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 62
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 59
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 58
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 58
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 58
Oxo-rhenium(V) mixed-ligand complexes with bidentate functionalized phosphines and tridentate Schiff base ligands 57
SITE-SPECIFIC [99mTc][Tc(CO)3(OH2)3]-LABELED scFvD2B-HysTag FOR SPECT IMAGING OF PSMA IN PROSTATE CANCER 57
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 56
[ 99m Tc][Tc(N)(DASD)(PNP n)] + (DASD = 1,4-Dioxa-8-azaspiro[4,5]decandithiocarbamate, PNP n = Bisphosphinoamine) for Myocardial Imaging: Synthesis, Pharmacological and Pharmacokinetic Studies 55
Water-Soluble [Tc(N)(PNP)] Moiety for Room-Temperature 99mTc Labeling of Sensitive Target Vectors 55
Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer 54
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 53
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 53
Radiopharmacological characterization of 64Cu-labeled alfa-MSH analogs for potential use in imaging of malignant melanoma 53
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 53
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 52
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 52
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 52
[99mTc][Tc(N)PNP]-tagging of the small RGDfK peptide: impact of different PNP structures on the labeling and pharmacokinetics of the radioconjugates 52
Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry 52
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 51
The emerging value of Cu-64 for molecular imaging and therapy 50
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 50
(Radio)pharmacological characterization of novel alpha-MSH derivatives 50
Synthesis, Characterization, and Initial Biological Evaluation of [99mTc]Tc-Tricarbonyl-labeled DPA-?-MSH Peptide Derivatives for Potential Melanoma Imaging 50
Synthesis, characterization and in vitro cytotoxicity of gallium(iii)-dithiocarbamate complexes 50
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 49
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 49
Cu-64-labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 49
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 48
Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. 47
Zirconium immune-complexes for PET molecular imaging: Current status and prospects 47
Synthesis and characterization of rhenium(III) complexes with pincer-like PNP(R) ligands 46
[Tc-99m(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 46
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 46
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 46
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 45
Radioactive Transition Metal Nitride Hetero-Complex 45
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 45
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 45
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 45
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 44
Syntheses and characterisation of rhenium-(III) and -(V) complexes containing aminophosphine ligands. Crystal structures of [Re-V(OCl2)(OMe)L] and [Re-III(Cl3L)(PPh3)], L equals o-(diphenylphosphino)-N,N'-dimethylaniline 44
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 43
'3+1' mixed-ligand oxotechnetium(V) complexes with affinity for melanoma: Synthesis and evaluation in vitro and in vivo 43
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 43
Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules 43
, [188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 42
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 42
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 42
Mixed Technetium-99m Nitrido Complexes with Dithiocarbamate and Phosphine-Thiol Ligands 41
Cu-64-dithiocarbamate compounds for theragnostic applications: Preliminary in-vitro studies 41
Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: Structural properties and DNA damage 41
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 41
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 41
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 41
Nitrido technetium-99m core in radiopharmaceutical applications: Four decades of research 41
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 40
Low-Valent Technetium Complexes with Aminodiphosphines 40
The emerging value of copper-64 for molecular imaging and therapy. 40
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 40
Synthesis and characterization of Oxorhenium(V) Complexes Containing o-diphenylphosphinophenolato and monothiolato lingands 39
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 39
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 38
A Bis(Thiosemicarbazone) bifunctional chelating agent for Nitrido-Tchnetium-99m and Copper 64-basedRadiopharmaceuticals 38
The (Tc(N)(PNP))(2+) metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies 38
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 37
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 36
A New series of [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 36
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 36
99mTc-Radiolabeled Peptides for Tumour Imaging: Present and Future 36
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 35
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 35
Radiochemical and radiopharmacological characterization of a Cu-64-labeled alpha-MSH analog conjugated with different chelators 35
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 35
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 35
New Tc-99m-radioimmunoconjugates for pancreatic carcinoma detection 34
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 34
Technetium and Rhenium in Five-Coordinate Symmetrical and Dissymmetrical Nitrido Complexes with Alkyl Phosphino-thiol Ligands. Synthesis and Structural Characterization 33
Quantitative YAP-(S)PET small animal scanner: Preliminary results 33
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 32
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 32
Alternative Synthesis of Aminodiphosphines 32
Totale 4.988
Categoria #
all - tutte 27.154
article - articoli 16.952
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 485
Totale 44.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202470 0 0 0 0 0 0 0 0 2 0 66 2
2024/20252.579 20 10 198 109 418 118 60 158 75 116 707 590
2025/20264.312 242 390 445 664 692 144 613 217 188 283 144 290
2026/2027283 262 21 0 0 0 0 0 0 0 0 0 0
Totale 7.244